These days, a cellphone is much more than just a phone – it’s a photo album, a GPS, a stereo system, an encyclopedia, a computer, a gaming system, a suite of tools all in the palm of your hand. One of the many tools that can be accessed via mobile technology are apps intended to help manage your health, sometimes known as mobile health technology.
On November 11, 2022, the U.S. Food and Drug Administration (FDA) announced it has approved the use of brentuximab vedotin (Adcetris), for pediatric patients 2 years of age and older with previously untreated high-risk classical Hodgkin lymphoma (cHL).
FDA announced it has approved the use of tisagenlecleucel (Kymriah, Novartis Pharmaceuticals Corporation) for the treatment of adult patients with relapsed or refractory follicular lymphoma (FL) after two or more lines of systemic therapy.
Stay informed with news, alerts and other resources.